Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...
Seventeen placebo-controlled trials across seven antibodies yielded statistically significant but clinically small mean ...
Anti-amyloid drugs likely provide no "clinically meaningful" effects for people with Alzheimer's, the authors concluded.
The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...
The long-promised breakthrough in Alzheimer’s treatment is now facing a stark and uncomfortable reckoning. A sweeping new ...
With few approved drugs available to treat Alzheimer disease, researchers are working on new compounds that block amyloid formation. But many potential drugs in the pipeline for the disease and other ...
This article originally appeared on Undark. For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive neurodegenerative disease that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results